原发性干燥综合征相关淋巴瘤:从自身免疫到淋巴瘤发生
本文综述了原发性干燥综合征(SS)患者淋巴瘤发生机制的最新进展,指出淋巴瘤是SS最严重的并发症和主要死亡原因。SS相关淋巴瘤多为黏膜相关淋巴组织(MALT)结外非霍奇金B细胞淋巴瘤,常起源于慢性炎症累及的唾液腺,与局部慢性抗原刺激B细胞的多步骤过程相关,肿瘤性B细胞常源自自身反应性克隆(尤其是产生类风湿因子(RF)的B细胞)。综述还讨论了识别B细胞恶性变关键因素对早期识别高危患者的意义,并提出了未来研究方向。
要点
- 淋巴瘤是SS最严重并发症和主要死亡因素,多为MALT结外非霍奇金B细胞淋巴瘤。
- SS淋巴瘤发生与局部慢性抗原刺激B细胞的多步骤过程相关,肿瘤细胞常源自自身反应性克隆。
- 寻找新生物标志物、开发验证的淋巴瘤预测评分及评估更好控制疾病活动是否降低淋巴瘤风险是未来重要方向。
核心结论
- SS中淋巴瘤的发生是一个与局部慢性抗原刺激B细胞相关的多步骤过程,肿瘤性B细胞常源自自身反应性克隆。
研究设计与样本
- 本文为综述,聚焦SS中淋巴瘤发生机制及自身免疫与淋巴瘤发生的紧密联系。
主要发现
- SS相关淋巴瘤多为黏膜相关淋巴组织结外非霍奇金B细胞淋巴瘤,常发生于作为慢性炎症靶点的唾液腺。
- SS中的肿瘤性B细胞常源自自身反应性克隆,最常见为产生类风湿因子的B细胞,发生不受控增殖和恶性逃逸。
临床怎么用
- 识别参与B细胞恶变的关键因素可能有助于早期识别淋巴瘤风险增高的SS患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lymphoma development is the most serious complication of SS and the main factor impacting on mortality rate in patients with this condition. Lymphomas in SS are most commonly extranodal non-Hodgkin B-cell lymphomas of the mucosa-associated lymphoid tissue and frequently arise in salivary glands that are the target of a chronic inflammatory autoimmune process. Extensive work on lymphomagenesis in SS has established that the progression towards B-cell lymphoma is a multistep process related to local chronic antigenic stimulation of B cells. These neoplastic B cells in SS frequently derived from autoreactive clones, most commonly RF-producing B cells, which undergo uncontrolled proliferation and malignant escape. In this review, we highlight the most important recent findings that have enhanced our understanding of lymphoma development in SS, with particular reference to the close link between autoimmunity and lymphomagenesis. We also discuss how the identification of key factors involved in B-cell malignancies may impact on our ability to identify at early stages patients at increased risk of lymphoma with potential significant repercussions for the clinical management of SS patients. Finally, we identified the most promising areas of current and further research with the potential to provide novel basic and translational discoveries in the field. The questions of finding new biomarkers, developing a validated score for predicting lymphoma occurrence and assessing if a better control of disease activity will decrease the risk of lymphoma in primary SS will be the enthralling questions of the next few years.
引用
- Nocturne G, Pontarini E, Bombardieri M, et al. Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford). 2021. PMID: 30838413. doi:10.1093/rheumatology/kez052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。